Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography–computed tomography?. (13th February 2018)

• Record Type: Journal Article
• Authors: Decaluwé, Herbert; Moons, Johnny; Fieuws, Steffen; De Wever, Walter; Deroose, Christophe; Stanzi, Alessia; Depypere, Lieven; Nackaerts, Kristiaan; Coolen, Johan; Lambrecht, Maarten; Verbeken, Eric; De Ruysscher, Dirk; Vansteenkiste, Johan; Van Raemdonck, Dirk; De Leyn, Paul; Dooms, Christophe
• Is Part Of: European journal of cardio-thoracic surgery. Volume 54:Number 1(2018)
• Page Start: 134
• Page End: 140
• Publication Date: 2018-02-13
• Subjects: Non-small-cell lung cancer -- Central tumour -- Nodal upstaging -- cN0 -- pN1 -- pN2; Heart -- Surgery -- Periodicals; Chest -- Surgery -- Periodicals; 617.54
• DOI: 10.1093/ejcts/ezy018
• Languages: English
• ISSNs: 1010-7940

Abstract

Abstract: OBJECTIVES: Current guidelines recommend preoperative invasive mediastinal staging in centrally located tumours with negative mediastinum on positron emission tomography–computed tomography, based on a 20–30% prevalence of occult mediastinal disease (pN2–3). However, a uniform definition of central tumour location is lacking. Our objective was to determine the best definition in predicting occult pN2–3. METHODS: A single-institution database was queried for patients with (suspected) non-small-cell lung cancer staged cN0 after positron emission tomography–computed tomography and referred to invasive staging and/or primary surgery. We evaluated 5 definitions: inner 1/3, inner 2/3, contact with bronchovascular structures, ≤2 cm from bronchus or endobronchial visualization. RESULTS: Between 2005 and 2015, 813 patients were eligible (cT1: 42%, cT2: 28%, cT3: 17% and cT4: 11%). Invasive mediastinal staging and resection were performed in 30% and 97% of patients, respectively. Any nodal upstaging (pN+) was found in 21% of patients, of whom pN2–3 was found in 8%. Central tumour location demonstrated 4 times higher odds for any pN+ [for inner 1/3 vs outer 2/3, odds ratio 3.90 (95% confidence interval 2.24–6.77), P < 0.001], whereas no significantly different odds was observed for pN2–3. The discriminative ability for pN+ was not significantly different between the several definitions. CONCLUSIONS: The prevalence of occult pN2–3 was only 8% when modern fusion positron emission tomography–computed tomography imaging pointed at clinical N0 non-small-cell lung cancer. None of the 5 verified definitions of centrality was predictive for occult pN2–3. However, each definition of centrality was related to any pN+ at a prevalence of 21%, without significant differences in discriminative ability between definitions. These data question whether indication for preoperative invasive mediastinal staging should be based on centrality alone.